PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of nihpaAbout Author manuscriptsSubmit a manuscriptNIH Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
 
J Am Med Dir Assoc. Author manuscript; available in PMC Nov 1, 2013.
Published in final edited form as:
PMCID: PMC3650646
NIHMSID: NIHMS413177
Impact of the Raising Immunizations Safely and Effectively (RISE) Program on Healthcare Worker Influenza Immunization Rates in Long-Term Care Settings
David A. Nace, MD, MPH, CMD,1 Steven M. Handler, MD, PhD, CMD,1,2,3,4 Erika L. Hoffman, MD,3 and Subashan Perera, PhD5
1Division of Geriatric Medicine, Department of Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania
2Department of Biomedical Informatics, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania
3Veterans Affairs Pittsburgh Healthcare System (VAPHS), Pittsburgh, Pennsylvania
4Geriatric Pharmaceutical Outcomes and Gero-Informatics Research and Training Program, University of Pittsburgh, Pittsburgh, Pennsylvania
5Department of Biostatistics, Graduate School of Public Health, University of Pittsburgh
Corresponding Author: David A. Nace, MD, MPH, CMD Department of Medicine Division of Geriatric Medicine University of Pittsburgh 3471 Fifth Ave, Suite 500 Pittsburgh, PA 15213 412-692-2360 (office phone) 412-692-2370 (fax) naceda/at/upmc.edu
Introduction and Rationale
National influenza immunization rates for healthcare workers (HCW) in long-term care (LTC) remain unacceptably low. This poses a serious public health threat to residents. Prior work has suggested high staff turnover rates as a contributing factor to low immunization rates. There is a critical need to identify and deploy successful models of HCW influenza immunization programs to LTC facilities. This report describes one potential model that has been successfully initiated in a network of LTC facilities.
Methods
All facilities served by a single regional LTC pharmacy were invited to participate in a HCW influenza immunization program. This voluntary immunization program began in 2005 and continues to the present. As part of the program, the pharmacy promoted organizational change by assuming oversight and control of HCW immunization policies and processes for all facilities. Primary and secondary outcomes are the number of facilities reaching HCW influenza immunization rates of 60% and 80%.
Results
Fourteen of the sixteen LTC facilities participated. Facilities were diverse and included both nursing and assisted living facilities; unionized and nonunionized facilities; and urban, suburban and rural facilities. The pharmacy provided educational and communication materials, centralized data collection using a standardized definition for HCW immunization rates, and facility feedback. All fourteen LTC facilities achieved the primary goal of 60% and nearly two thirds reached the secondary goal of 80%. Twenty percent reached the new Healthy People 2020 goal of 90%.
Discussion
It is possible for LTC facilities to improve HCW immunization rates using a pharmacy based, voluntary HCW influenza immunization approach. Such an approach may help attenuate the negative influence of staff turnover on HCW immunizations. Attainment of the new Health People 2020 goals still remains a challenge and may require mandatory programs.
Keywords: healthcare workers, healthcare worker immunization, immunization programs, long-term care, nursing homes, immunizations, influenza
Influenza remains a serious public health threat with as many as 225,000 hospitalizations and roughly 24,000 deaths annually in the United States.1, 2 Over 90% of the deaths from seasonal influenza occur in older adults, particularly frail elders such as those residing in long-term care (LTC) settings.1 While annual vaccination of older adults is recommended, vaccine efficacy is reduced among elders.1, 3-6 Potential reasons may include age-related immunosenescence, immunosuppression, and malnutrition.7-11 Thus, it is not surprising that influenza outbreaks in LTC settings continue to occur regularly, and are associated with significant case fatality rates. 12-14
Frequently, healthcare workers (HCW) are potential vectors for influenza transmission in LTC.15, 16 Immunization of HCW is promoted as a patient safety practice, and may also protect employees against the spread of influenza. Several studies support the practice of HCW influenza immunization by showing a reduction in influenza illness and resident mortality in LTC facilities.17-21 The Centers for Disease Control and Prevention (CDC) established Healthy People 2010 and 2020 goals of 60% and 90% for HCW influenza immunization respectively.22, 23 Despite persistent efforts by multiple organizations to improve HCW immunization, HCW influenza immunization rates remain unacceptably low.1, 24-26
While several studies have shown it is possible to improve HCW immunization rates at single facilities, there is a public health need to develop approaches to improving rates across groups or networks of facilities.27-29 Published studies of such efforts to date have shown only modest impact. 30, 31 We recently reported on efforts to deploy a successful HCW immunization program to a network of facilities.32 Like other studies, the outcomes of this pilot intervention were modest, but we were able to identify a previously unrecognized barrier to HCW immunization: staff turnover. High staff turnover in LTC is well-documented and may result in decreased compliance with policies and hence measured quality.33-35 A potential strategy to circumvent the impact of staff turnover on immunization rates is to assign responsibility and oversight of HCW immunizations at each facility to the LTC pharmacy.
To test this strategy, we initiated a quality improvement (QI) project in which HCW immunizations were overseen and managed by the LTC pharmacy. Specifically, the goal of this QI project was to achieve a 60% HCW influenza immunization rate across a network of independently-owned LTC facilities in Western PA. This report summarizes our experience to date.
In 2001 the University of Pittsburgh Medical Center formed the Raising Immunizations Safely and Effectively (RISE) program, a QI network aimed at improving immunization rates in a group of LTC facilities in western Pennsylvania. Initially focusing on resident immunization rates, the program was expanded in 2004 to address low HCW influenza immunization rates (RISE-HCW).
Facilities invited to participate in the RISE-HCW network included both nursing and assisted living facilities served by a single regional LTC pharmacy. Participating facilities had to agree to change their current HCW immunization processes and adopt the RISE-HCW program. In doing so, facilities had to specifically transfer the location of HCW immunization policies and procedures from the domain of nursing (Nursing Policy and Procedure Manual) to that of the pharmacy (Pharmacy Policy and Procedure Manual). In addition, facilities had to agree to work collaboratively with the pharmacy to address issues of vaccine supply and ordering, revision of HCW consent processes, vaccine administration and record keeping, data collection, and staff feedback. Facilities were expected to designate an immunization champion, participate in educational activities and ensure leadership support. Educational materials were provided by the RISE-HCW program (available upon request from the authors).
The primary outcome of the program was the number of facilities reaching the Healthy People 2010 HCW influenza immunization rate of 60% and a secondary outcome measure was the number of facilities reaching a stretch goal of 80% HCW influenza immunization rate. Influenza immunization rates were collected annually from participating facilities using a standardized definition for HCW influenza immunization rates adopted by all facilities. The HCW influenza immunization rate was defined as all persons, regardless of level of patient contact, receiving a paycheck from the facility between October 1 and April 1 of each influenza season who received influenza vaccination divided by all persons employed at the facility for any length of time between October 1 and April 1 of each season, multiplied by 100. Volunteers, physicians, and contracted non-employees were not included in the calculation owing to the inability to track these individuals at each facility.
For this project, the baseline (pre-intervention) period included the 2001-2002 through 2003-2004 seasons. A national influenza vaccine shortage occurred during the 2004-2005 season which delayed the start of the RISE-HCW program to the subsequent season (2005-2006). Annual immunization rates are reported for each influenza season starting in 2001-2002 as available: not all facilities had monitored HCW immunization rates prior to the 2004-2005 season, and not all were not using the definition adopted for this project. Data is not shown for the 2004-2005 season given the national vaccine shortage during that period. The organizational structure and information on bed size, location, and number of employees is presented. Since this is a QI project, more detailed demographic information concerning the facilities is not available and information on influenza outbreaks for each of the facilities was not tracked as part of this project.
This program was reviewed by the UPMC QI Committee and approved as a QI project. As this project does not meet the definition of human subject research, it was exempted from review by the University of Pittsburgh Institutional Review Board.
Of the sixteen facilities served by the LTC pharmacy, fourteen agreed to participate in the RISE-HCW program. Two facilities did not participate in the QI project because they felt that their current HCW immunization policies and processes were effective. Nine of the fourteen facilities were part of the UPMC Senior Communities network and the remaining five were independently owned and operated. All were of non-profit status. Table 1 describes the characteristics of the facilities. Facilities included rural, suburban and urban sites. The facility bed-size ranged from 45 to 440 beds and the number of staff varied from 38 to 527 as of 2010. Two of the facilities employed unionized staff during all or part of the intervention period.
Table 1
Table 1
Facility Characteristics
A steering committee oversaw the operations of the RISE-HCW program. The steering committee was comprised of representatives from the participating facilities and includes pharmacy, nursing, administrative, and medical disciplines. The organizational structure of the RISE-HCW program is available online in the Appendix. The steering committee initially met five times a year, but by 2009-2010 reduced the meeting frequency to annually.
The LTC pharmacy implemented a HCW influenza immunization program at each facility utilizing insights and strategies gained from our past work and the work of others.27, 32, 36, 37 Specifically, the pharmacy provided written immunization policies, educational flyers and posters, a standard declination form, and data collection forms. These intervention components were made available to all sites. Immunization policies emphasized immunization of all staff employed at the facilities, allowed for no cost vaccination of HCW, provided for vaccination of HCW during all shifts both on and off work units, and utilized standing orders. The policies also addressed resident vaccinations, influenza surveillance and outbreak response. Written consent documents were eliminated as they are not required by state or federal legislation, represent a time consuming barrier, and are not considered a standard of care.38, 39 The pharmacy assisted in providing in-service training programs for staff members, established a HCW vaccination clinic “kick-off” event for each facility each season, and tracked immunization rates. Facilities were provided with the AMDA training video “Immunization and the HCW” that they could use for HCW in-service sessions. Feedback to facilities on immunization rates was provided including individual facility performance and benchmark data for the group. Also, an email distribution list was created and utilized to assist with questions, provide performance feedback, and update members on influenza prevention and management topics. Facilities were not required to use all of the educational materials. Initially, not all facilities used the declination forms, but by the last two seasons, all facilities were using declination forms. No facility disciplined unvaccinated HCW for failing to sign a declination form. Like-wise, no facility required unvaccinated HCW to wear a mask during flu season.
Annual HCW influenza immunization rates for each facility are shown in Figure 1. As a group, rates of HCW immunization for influenza increased steadily over time from approximately 58% in 2005-2006 to 76% in 2010-2011. Figure 1(a) compares HCW immunization rates pre- and post-intervention for those facilities providing baseline immunization rates (seasons 2001-2002 through 2003-2004). Post-intervention results from all fourteen facilities are shown in Figure 1(b). As seen in Figure 1(c), of the fourteen facilities, all facilities reached a 60% HCW immunization rate by the last season. Eight (57%) achieved an 80% or better rate, and three exceeded 90%.
Figure 1
Figure 1
Figure 1
Figure 1
Percent of HCW Immunized (a) for Facilities with Pre- and Post-Intervention Data and (b) Post-Intervention in All Facilities. Figure 1(c) shows immunization rates for all facilities as of the 2010-2011 season.
In this study, we demonstrated it is possible to improve HCW influenza immunization rates in a network of LTC facilities served by a single LTC pharmacy. Facilities participating in the RISE program were able to reach the primary goal of 60%, almost two thirds reached the secondary goal of 80% or better, and 20% reached the new Healthy People 2020 goal. The rates demonstrated here are some of the highest reported for a network of independent LTC facilities using a voluntary approach. The impact of this program is significant, affecting over 2400 HCW and over 1800 LTC residents.
By having the LTC pharmacy oversee and administer the program, we were able standardized the emphasis on HCW influenza immunizations across all facilities. In addition, we believe we were able to overcome some of the issues related to staff turnover and competing demands on staff attention. In prior work, we found that despite educational interventions and centralization of immunization policies at the facility level, we were unable to achieve national immunization goals.32 High staff turnover is a pervasive issue in LTC and is linked to lower quality of care.33 When turnover is high, consistent application of facility policies may suffer. This may be particularly true with influenza immunization as nursing staff frequently view immunization as a personal choice rather than as an organizational evidence-based intervention.40 In contrast, LTC facilities do not typically change their LTC pharmacy provider annually and so enjoy a stable presence. Administering the immunization program via the LTC pharmacy should result in a more consistent effort across years. Our current findings support this, and in addition correlate with immunization programs using pharmacists in acute care settings.41
We believe the structure of the RISE program contributed to its success. The RISE program makes use of a LTC pharmacy network serving multiple different facilities, a model consistent with most LTC facilities across the country. The RISE program is structured similarly to that described by Babcock and co-workers at their health system.42 In that study, a representative from each facility in the health system participated in a system-wide council that planned and coordinated education, policies and procedures relating to HCW immunizations. Use of a central steering group promotes coordination across sites. Our study is unique in that not all of the participating facilities were part of the same health system and thus were individually managed.
Our program has several limitations. First, all facilities participating in the RISE program were non-profit organizations which limits generalizability. Participating facilities had to transfer oversight of the immunization program to the LTC pharmacy. This may not be possible for some chain facilities in which immunization policies are standardized centrally. In such facilities, it may not be possible to gain the necessary permission to shift location of immunization policies to the LTC pharmacy. Secondly, the RISE program requires significant ongoing efforts to ensure sustainability. While the number of steering group meetings were reduced over time to just one per year, the RISE program still relies heavily on the efforts of each facility’s leadership and champions. Thirdly, we did not track immunization rates for volunteers, physicians, or contracted non-employees. Immunization of these groups is a significant challenge to most LTC facilities. Fortunately, these groups represent only a fraction of the total HCW population of the facilities. Lastly, the RISE program is a voluntary program. While all facilities currently utilize declination forms for HCW declining influenza immunization, no facility imposes any form of disciplinary action for noncompliance, and no facility requires non-immunized HCW to wear masks during the active influenza season. Mandatory immunization programs have been associated with substantially higher HCW immunization rates, and there are strong ethical arguments for their use.42-45 Several organizations including AMDA now advocate for mandatory immunization programs.46 As shown in Figure 1, there appears to be a plateau occurring in HCW immunization rates for this group of facilities. We believe it is unlikely that most facilities will be able to reach the Healthy People 2020 HCW immunization goal of 90%.
Strengths of our program include the use of standardized declination forms, immunization policies, data collection tools, and importantly, a standard definition of HCW immunization rate. We also provided evidence-based educational materials, an email communication process, and performance feedback.
In summary, we show that through collaborative efforts, LTC facilities sharing a common pharmacy provider can improve their HCW immunization rates. By having the LTC pharmacy oversee and administer the HCW immunization program, it may be possible to reduce the negative impact of high staff turnover in these settings. While nearly two thirds of the facilities reached 80% or better, only 3 exceeded 90% despite detailed, iterative efforts. If we hope to reach the 90% Healthy People 2020 goal, facilities may need to consider exploring mandatory programs.
Supplementary Material
01
Acknowledgments
Funding Sources Support for this project was provided by the AMDA Foundation / Pfizer 2002 QIAward, the Pittsburgh Claude D. Pepper Older Americans Independence Center (NIH P30 AG024827), the Pharmaceutical Outcomes Research in Aging Program (NIH K07 AG033174), and the Agency for Healthcare Research and Quality (AHRQ R01HS018721).
Appendix
figure nihms-413177-f0004
Organizational Structure of the RISE-HCW Program
Footnotes
This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
Conflict of Interest Statement: The primary author currently receives grant support from Sanofi Pasteur as principle investigator for an investigator initiated study evaluating the impact of regular versus high dose influenza vaccine in long-term care residents. There are no other conflicts any of the authors.
1. Fiore AE, Shay DK, Broder K, et al. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Recomm Rep. 2009 Jul 31;58(RR-8):1–52. [PubMed]
2. Centers for Disease C, Prevention Estimates of deaths associated with seasonal influenza --- United States, 1976-2007. MMWR Morb Mortal Wkly Rep. 2010 Aug 27;59(33):1057–1062. [PubMed]
3. Horman JT, Stetler HC, Israel E, Sorley D, Schipper MT, Joseph JM. An outbreak of influenza A in a nursing home. American Journal of Public Health. 1986 May;76(5):501–504. [PubMed]
4. Taylor JL, Dwyer DM, Coffman T, Groves C, Patel J, Israel E. Nursing home outbreak of influenza A (H3N2): evaluation of vaccine efficacy and influenza case definitions. Infect Control Hosp Epidemiol. 1992 Feb;13(2):93–97. [PubMed]
5. Jefferson T, Rivetti D, Rivetti A, Rudin M, Di Pietrantonj C, Demicheli V. Efficacy and effectiveness of influenza vaccines in elderly people: a systematic review. Lancet. 2005 Oct 1;366(9492):1165–1174. [PubMed]
6. Osterholm MT, Kelley NS, Sommer A, Belongia EA. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect Dis. 2012;12(1):36–44. [PubMed]
7. Grubeck-Loebenstein B, Della Bella S, Iorio AM, Michel JP, Pawelec G, Solana R. Immunosenescence and vaccine failure in the elderly. [Review] [85 refs] Aging Clinical & Experimental Research. 2009 Jun;21(3):201–209. [PubMed]
8. Sasaki S, Sullivan M, Narvaez CF, et al. Limited efficacy of inactivated influenza vaccine in elderly individuals is associated with decreased production of vaccine-specific antibodies. Journal of Clinical Investigation. 2011 Aug 1;121(8):3109–3119. [PMC free article] [PubMed]
9. Fulop T, Pawelec G, Castle S, Loeb M. Immunosenescence and vaccination in nursing home residents. [Review] [52 refs] Clin Infect Dis. 2009 Feb 15;48(4):443–448. [PubMed]
10. Fulop T, Wagner R, Khalik A. Relationship between the resonse to influenza vaccination and the nutritional status in institutionalized elderly subjects. J Gerontol Med Sci. 1999;54A:M59–64. al. e. [PubMed]
11. Potter JM, O’Donnel B, Carman WF, Roberts MA, Stott DJ. Serological response to influenza vaccination and nutritional and functional status of patients in geriatric medical long-term care. Age Ageing. 1999 Mar;28(2):141–145. [PubMed]
12. Simor A. Influenza outbreaks in long-term-care facilities: How can we do better? Infect Control Hosp Epidemiol. 2002 Oct;23(10):564–567. [PubMed]
13. Goodman R, Orenstein W, Munro T, Smith S, Sikes R. Impact of influenza A in a nursing home. Journal of the American Medical Association. 1982 Mar 12;247(10):1451–1453. [PubMed]
14. Morens D, Rash V. Lessons from a nursing home outbreak of influenza A. Infect Control Hosp Epidemiol. 1995 May;16(5):275–280. [PubMed]
15. Poland GA, Tosh P, Jacobson RM. Requiring influenza vaccination for health care workers: seven truths we must accept. Vaccine. 2005;23:2251–2255. [PubMed]
16. Talbot T, Bradley S, Cosgrove S, Ruef C, Seigel J, Weber D. Influenza vaccination of healthcare workers and vaccine allocation for healthcare workers during vaccine shortages. Infect Control Hosp Epidemiol. 2005;26(11):882–890. [PubMed]
17. Potter J, Stott DJ, Roberts MA, et al. Influenza vaccination of health care workers in long-term-care hospitals reduces the mortality of elderly patients. J Infect Dis. 1997 Jan;175(1):1–6. [PubMed]
18. Carman WF, Elder AG, Wallace LA, et al. Effects of influenza vaccination of health-care workers on mortality of elderly people in long-term care: a randomised controlled trial. Lancet. 2000 Jan 8;355(9198):93–97. [PubMed]
19. Hayward AC, Harling R, Wetten S, et al. Effectiveness of an influenza vaccine programme for care home staff to prevent death, morbidity, and health service use among residents: cluster randomised controlled trial. BMJ. 2006 Dec 16;333(7581):1241–1246. [PMC free article] [PubMed]
20. Salgado C, Giannetta E, Hayden F, Farr B. Preventing nosocomial influenza by improving the vaccine acceptance rate of clinicians. Infect Control Hosp Epidemiol. 2004 Nov;25(11):923–928. [PubMed]
21. Shugarman LR, Hales C, Setodji CM, Bardenheier B, J L. The influence of staff and resident immunization ratees on influenza-like illness outbreaks in nursing homes. Journal of the American Medical Directors Association. 2006;7(9):562–567. [PubMed]
22. US Department of Health and Human Services Healthy People 2010 Midcourse Review. U.S. Government Printing Office; Washington, DC: 2006.
23. US Department of Health and Human Services [Accessed February 28, 2012];HealthyPeople.gov. 2012 http://www.healthypeople.gov/2020/default.aspx.
24. Walker F, Singleton J, Lu P, Wooten K, Strikas R. Influenza vaccination of healthcare workers in the United States, 1989-2002. Infect Control Hosp Epidemiol. 2006 Mar;27(3):257–265. [PubMed]
25. Centers for Disease C, Prevention Influenza vaccination coverage among health-care personnel --- United States, 2010-11 influenza season. MMWR Morb Mortal Wkly Rep. 2011 Aug 19;60(32):1073–1077. [PubMed]
26. Centers for Disease C, Prevention Interim results: influenza A (H1N1) 2009 monovalent and seasonal influenza vaccination coverage among health-care personnel - United States, August 2009-January 2010. MMWR Morb Mortal Wkly Rep. 2010 Apr 2;59(12):357–362. [Erratum appears in MMWR Morb Mortal Wkly Rep. 2010 Apr 9;59(13):397] [PubMed]
27. Nace D, Hoffman E, Resnick N, Handler S. Achieving and sustaining high rates of influenza immunization among long-term care staff. Journal of the American Medical Directors Association. 2007 Feb;8(2):128–133. [PubMed]
28. Thomas D, Winsted B, Koontz C. Improving neglected influenza vaccination among healthcare workers in long-term care. J Am Geriatr Soc. 1993 Sep;41(9):928–930. [PubMed]
29. Sartor C, Tissot-Dupont H, Zandotti C, Martin F, Roques P, Drancourt M. Use of a mobile cart influenza program for vaccination of hospital employees. Infect Control Hosp Epidemiol. 2004 Nov;25(11):918–922. [PubMed]
30. Centers for Disease Control and Prevention Interventions to increase influenza vaccination of health-care workers - California and Minnesota. MMWR Morb Mortal Wkly Rep. 2005;54(8):196–199. [PubMed]
31. Sand K, Lynn J, Bardenheier B, Soew H, Nace D. Increasing influenza immunization for long-term care facility staff using quality improvement. J Am Geriatr Soc. 2007 Nov;55(11):1741–1747. [PubMed]
32. Nace DA, Perera S, Handler SM, Muder R, Hoffman EL. Increasing Influenza and Pneumococcal Immunization Rates in a Nursing Home Network. Journal of the American Medical Directors Association. 2011;12(9):678–684. [PubMed]
33. Castle NG, Engberg J, Men A. Nursing home staff turnover: impact on nursing home compare quality measures. Gerontologist. 2007 Oct;47(5):650–661. [PubMed]
34. Donoghue C. Nursing Home Staff Turnover and Retention. Journal of Applied Gerontology. 2010 Feb 1;29(1):89–106. 2010.
35. Decker F, Gruhn P, Matthews-Martin L, Dollard K, Tucker A, Bizette L. [July 7, 2006];Results of the 2002 AHCA Survey of Nursing Staff Vacancy and Turnover in Nursing Homes. 2003 http://www.ahca.org/research/rpt_vts2002_final.pdf.
36. Nace DA. Improving immunization rates in long-term care: where the forest stops and the trees begin. Journal of the American Medical Directors Association. 2008 Nov;9(9):617–621. [PubMed]
37. Nace DA, Drinka P, Mann J, Poland GA. In: LTC Information Series: Immunization in the Long-Term Care Setting. 2 ed AMDA, editor. AMDA; Columbia, MD: 2010.
38. Kissam S, Gifford D, Patry G, Bratzler D. Is signed consent for influenza or pneumococcal polysaccharide vaccination required? Arch Intern Med. 2004 Jan 12;164(1):13–16. [PubMed]
39. Stefanacci R. Creating artificial barriers to vaccinations. Journal of the American Medical Directors Association. 2005 Sep-Oct;6(5):357–358. [PubMed]
40. Rhudy LM, Tucker SJ, Ofstead CL, Poland GA. Personal choice or evidence-based nursing intervention: nurses’ decision-making about influenza vaccination. Worldviews on Evidence Based Nursing. 2010 Jun 1;7(2):111–120. [PubMed]
41. Bourdet SV, Kelley M, Rublein J, Williams DM. Effect of a pharmacist-managed program of pneumococcal and influenza immunization on vaccination rates among adult inpatients. American Journal of Health System Pharmacy. 2003 Sep 1;60(17):1767–1771. [PubMed]
42. Babcock HM, Gemeinhart N, Jones M, Dunagan WC, Woeltje KF. Mandatory influenza vaccination of health care workers: translating policy to practice. Clin Infect Dis. 2010 Feb 15;50(4):459–464. [PubMed]
43. Rakita RM, Hagar BA, Crome P, Lammert JK. Mandatory influenza vaccination of healthcare workers: a 5-year study. Infect Control Hosp Epidemiol. 2010 Sep;31(9):881–888. [PubMed]
44. Esolen LM, Kilheeney KL, Merkle RE, Bothe A. An Alternate Approach to Improving Healthcare Worker Influenza Vaccination Rates. Infection Control and Hospital Epidemiology. 2011;32(7):703–705. [PubMed]
45. Tilburt JC, Mueller PS, Ottenberg AL, Poland GA, Kioenig BA. Facing the challenges of influenza in healthcare settings: the ethical rationale for mandatory seasonal influenza vaccination and its implications for future pandemics. Vaccine. 2008 Sep 12;26(Suppl 4):D27–30. [PubMed]
46. AMDA [Accessed March 2011];J11 Mandatory Immunization for Long Term Care Workers. 2011 http://www.amda.com/governance/resolutions/J11.cfm.